User profiles for "author:Stuart McPherson"

Stuart McPherson

Newcastle
Verified email at nhs.net
Cited by 8411

[HTML][HTML] Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis

RS Taylor, RJ Taylor, S Bayliss, H Hagström, P Nasr… - Gastroenterology, 2020 - Elsevier
Background & Aims Biopsy-confirmed liver fibrosis is a prognostic factor for patients with
nonalcoholic fatty liver disease (NAFLD). We performed a systematic review to quantify the …

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

JK Dyson, QM Anstee, S McPherson - Frontline gastroenterology, 2014 - fg.bmj.com
Non-alcoholic fatty liver disease (NAFLD) is now the commonest cause of abnormal liver
function tests (LFTs) in the UK with approximately a third of the population being affected …

Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver …

S McPherson, MJ Armstrong, JF Cobbold… - The lancet …, 2022 - thelancet.com
Non-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the
general population. The evidence base for the investigation and management of NAFLD is …

[HTML][HTML] Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

S McPherson, T Hardy, E Henderson, AD Burt… - Journal of …, 2015 - Elsevier
Background and Aims There remains uncertainty about the natural history of non-alcoholic
fatty liver disease (NAFLD). The spectrum of NAFLD includes non-alcoholic fatty liver (NAFL; …

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

S McPherson, SF Stewart, E Henderson, AD Burt… - Gut, 2010 - gut.bmj.com
Background Accurate evaluation of liver fibrosis in patients with non-alcoholic fatty liver
disease (NAFLD) is important to identify patients who may develop complications. The aim …

[HTML][HTML] TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

YL Liu, HL Reeves, AD Burt, D Tiniakos… - Nature …, 2014 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is an increasingly common condition, strongly
associated with the metabolic syndrome, that can lead to progressive hepatic fibrosis …

Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis

S McPherson, T Hardy, JF Dufour, S Petta… - Official journal of the …, 2017 - journals.lww.com
OBJECTIVES: Non-invasive fibrosis scores are widely used to identify/exclude advanced
fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). However, these scores …

How big a problem is non-alcoholic fatty liver disease?

QM Anstee, S McPherson, CP Day - Bmj, 2011 - bmj.com
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of liver disease
encompassing simple fatty infiltration (steatosis), fat and inflammation (non-alcoholic …

[HTML][HTML] Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial

D Houghton, C Thoma, K Hallsworth, S Cassidy… - Clinical …, 2017 - Elsevier
Background & Aims Pharmacologic treatments for nonalcoholic steatohepatitis (NASH) are
limited. Lifestyle interventions are believed to be effective in reducing features of NASH …

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered

S McPherson, JR Jonsson, GJ Cowin, P O'Rourke… - Journal of …, 2009 - Elsevier
BACKGROUND/AIMS: Currently the diagnosis and severity of hepatic steatosis can be
established accurately only by liver biopsy. Previous small studies found that steatosis …